1872-7786 < 1872-7913 < 1872-8227

Facettes : Author.f

List of bibliographic references

Number of relevant bibliographic references: 66.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000233 (2021)	Alexis Lacout ; Valere Lounnas ; Christian Perronne	Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.
000245 (2021)	Hervé Seligmann	Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment.
000326 (2021)	Nicolas Dauby ; Joris Hautekiet ; Lucy Catteau ; Marion Montourcy ; Dominique Van Beckhoven ; Emmanuel Bottieau ; Els Goetghebeur	Reply to "The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of 'goals of care'".
000327 (2021)	Prof Imad M. Tleyjeh ; Haytham Tlayjeh	Perceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of "goals of care".
000336 (2021)	Philippe Gautret ; Van Thuan Hoang ; Philippe Colson ; Didier Raoult	Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.
000458 (2021)	O. Belfaqeeh ; R N Janapala ; J. Patel ; A. Alhashmi ; A. Pourmand	Azithromycin, a questionable treatment for COVID-19.
000527 (2021)	Philippe Gautret ; Jean-Christophe Lagier ; Stéphane Honoré ; Van Thuan Hoang ; Didier Raoult	Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.
000528 (2021)	Guogen Shan ; Weizhen Wang	Advanced statistical methods and designs for clinical trials for COVID-19.
000529 (2021)	Philippe Gautret ; Van Thuan Hoang ; Stéphane Honoré ; Yanis Roussel ; Matthieu Million ; Jean-Christophe Lagier ; Didier Raoult	Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
000530 (2021)	Philippe Colson ; Bernard La Scola ; Jean-Christophe Lagier ; Philippe Gautret ; Didier Raoult	Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
000531 (2021)	Philippe Gautret ; Van Thuan Hoang ; Jean-Christophe Lagier ; Didier Raoult	Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.
000532 (2021)	Philippe Gautret ; Van Thuan Hoang ; Jean-Christophe Lagier ; Didier Raoult	Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
000533 (2021)	Tuan V. Nguyen	Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.
000534 (2021)	Philippe Gautret ; Stéphane Honoré ; Jean-Christophe Lagier ; Didier Raoult	Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
000535 (2021)	Mohamed O. Saad	Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
000536 (2021)	Marcelo Rodrigues Dos Santos	Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.
000537 (2021)	Carlos Gustavo Wambier	Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
000538 (2021)	Jason D. Goldman ; George Diaz ; Walter J. Urba	Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
000539 (2021)	Matthieu Million ; Yanis Roussel ; Philippe Gautret ; Didier Raoult	Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
000540 (2021)	Alexandre Elias Malek ; Bruno P. Granwehr	Doxycycline as an Alternative to Azithromycin in Elderly Patients.
000541 (2021)	Luis Gabriel Parra-Lara ; Juan José Martinez-Arboleda ; Daniel Francisco Isaza-Pierotti ; Fernando Rosso	Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i -k "1872-7913" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i  \
                -Sk "1872-7913" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1872-7913
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021